Along with minimizing the risks for post-surgical infections and complications, the SRT-100™ provides patients and physicians with a safe and effective treatment option that offers many benefits.
By delivering a precise, calibrated dose of Superficial Radiation Therapy that only goes skin deep, patients can be safely treated right in their physician’s office. Each treatment is virtually painless.
Low-dose Superficial Radiation Therapy effectively destroys basal cell carcinoma and squamous cell carcinoma, as well as the non-malignant tumor cells that cause keloids. Best of all, it doesn’t involve cutting, bleeding or stitching. With the SRT-100™, there is no need for anesthesia, minimal risk of infection or scarring, no need for reconstructive plastic surgery. Patients heal quickly and don’t have downtime or lifestyle restrictions following treatment.
Sensus Healthcare’s SRT-100™ has been cleared by the U.S. Food and Drug Administration for the treatment of non-melanoma skin cancer and keloids. It is ideal for private dermatology and oncology practices, as well as hospitals and multi-locale healthcare providers.
The horizontal and vertical range of the scissor arm accommodates your patients whether they’re sitting or recumbent.
Casters and a small footprint (30” x 30”) lets you place the system where it needs to be.
Pre-treatment energy verification as part of a daily QC program for precise and accurate x-ray delivery.
Automatic warm-up procedure allows for time-efficient system setup and patient treatment. The treatment dose is automatically displayed for verification prior to delivery.
Large range of motion makes the SRT-100™ accommodating to patients in wheelchairs.
High-frequency inverter technology utilizes feedback sensing to maintain stable kV-mA energy levels.
Contact shields, variable applicator sizes, and replaceable contact shields provide 1.27 cm visual verification and clinical margin clearance of the treated area. Replacement shields are inexpensive and ensure shields do not discolor. Use of replacement shields also helps prevent blood-borne pathogen transmission.
Upon kV-mA selection, the system automatically changes the aluminum filter, eliminating the need for filter storage, manual procedures, and the potentially adverse possibility of inadvertent over-dosage or under-dosage.